Literature DB >> 32216966

Impact of scFv structure in chimeric antigen receptor on receptor expression efficiency and antigen recognition properties.

Kento Fujiwara1, Mizuki Masutani1, Masashi Tachibana1, Naoki Okada2.   

Abstract

Gene-modifying T cells expressing chimeric antigen receptor (CAR) with an extracellular domain consisting of single chain variable fragment (scFv) and an intracellular domain with a T cell activation motif, are promising cancer immuno-medicines that can exert long term potent antitumor activity. However, CAR-T cells have a high risk of causing fatal side effects. Thus, more effective and safer CAR-T cells are urgently needed. Although antigen specificity and reactivity of CAR-T cells are defined by CAR expression level and affinity, information on optimizing the scFv structure that defines CAR avidity is lacking. Here, we investigated the impacts of scFv substitution and structural modification in CAR on receptor expression and antigen recognition properties. Four CARs with distinct scFvs targeting the same antigen were unexpectedly separated into a CAR expressed on T cells and bound to the antigen, CARs that did not show antigen-binding because of cell surface aggregation, and a rarely expressed CAR. Among the scFv structural modifications of CARs, changes in the Fv order and linker did not noticeably affect CAR expression or antigen-binding. In contrast, complementarity-determining region (CDR)-grafting to the stable framework region in Fv dramatically improved the surface expression level of non-producible CAR. These results revealed that CAR expression efficiency and stability on T cells are influenced by the Fv structure. Therefore, stabilization of the Fv structure by CDR-grafting may be an effective means for expressing scFvs, which have excellent antigen specificity and appropriate affinity but low structural stability, as a CAR on T cells.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antigen recognition domain; CDR-grafting; Chimeric antigen receptor; Fv structure; Structural form of scFv

Mesh:

Substances:

Year:  2020        PMID: 32216966     DOI: 10.1016/j.bbrc.2020.03.071

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Binding and Efficacy of Anti-Robo4 CAR-T Cells against Solid Tumors.

Authors:  Sachiko Hirobe; Seina Nagai; Masashi Tachibana; Naoki Okada
Journal:  Biomedicines       Date:  2022-05-30

Review 2.  Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy.

Authors:  Ying Gong; Roel G J Klein Wolterink; Jianxiang Wang; Gerard M J Bos; Wilfred T V Germeraad
Journal:  J Hematol Oncol       Date:  2021-05-01       Impact factor: 17.388

Review 3.  Chimeric Antigen Receptor Based Therapy as a Potential Approach in Autoimmune Diseases: How Close Are We to the Treatment?

Authors:  Muhammad Sadeqi Nezhad; Alexander Seifalian; Nader Bagheri; Sajad Yaghoubi; Mohammad Hossein Karimi; Meghdad Adbollahpour-Alitappeh
Journal:  Front Immunol       Date:  2020-11-26       Impact factor: 7.561

Review 4.  Chimeric Antigen Receptor T-Cell Therapy in Lung Cancer: Potential and Challenges.

Authors:  Bu-Fan Xiao; Jing-Tao Zhang; Yu-Ge Zhu; Xin-Run Cui; Zhe-Ming Lu; Ben-Tong Yu; Nan Wu
Journal:  Front Immunol       Date:  2021-11-01       Impact factor: 7.561

Review 5.  Engineered NK Cells Against Cancer and Their Potential Applications Beyond.

Authors:  Maria Karvouni; Marcos Vidal-Manrique; Andreas Lundqvist; Evren Alici
Journal:  Front Immunol       Date:  2022-02-15       Impact factor: 7.561

6.  The Effects of Chimeric Antigen Receptor (CAR) Hinge Domain Post-Translational Modifications on CAR-T Cell Activity.

Authors:  Sachiko Hirobe; Keisuke Imaeda; Masashi Tachibana; Naoki Okada
Journal:  Int J Mol Sci       Date:  2022-04-06       Impact factor: 5.923

7.  Hinge and Transmembrane Domains of Chimeric Antigen Receptor Regulate Receptor Expression and Signaling Threshold.

Authors:  Kento Fujiwara; Ayaka Tsunei; Hotaka Kusabuka; Erika Ogaki; Masashi Tachibana; Naoki Okada
Journal:  Cells       Date:  2020-05-09       Impact factor: 6.600

Review 8.  Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments.

Authors:  Annamaria Sandomenico; Jwala P Sivaccumar; Menotti Ruvo
Journal:  Int J Mol Sci       Date:  2020-08-31       Impact factor: 5.923

Review 9.  NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful Development.

Authors:  Ali Bashiri Dezfouli; Mina Yazdi; Alan Graham Pockley; Mohammad Khosravi; Sebastian Kobold; Ernst Wagner; Gabriele Multhoff
Journal:  Cells       Date:  2021-12-01       Impact factor: 6.600

10.  A cell-based phenotypic library selection and screening approach for the de novo discovery of novel functional chimeric antigen receptors.

Authors:  Julie K Fierle; Johan Abram-Saliba; Vasileios Atsaves; Matteo Brioschi; Mariastella de Tiani; Patrick Reichenbach; Melita Irving; George Coukos; Steven M Dunn
Journal:  Sci Rep       Date:  2022-01-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.